SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-051181
Filing Date
2017-08-11
Accepted
2017-08-11 06:56:09
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13386_110q.htm 10-Q 782756
2 EX-31.1 a17-13386_1ex31d1.htm EX-31.1 10175
3 EX-31.2 a17-13386_1ex31d2.htm EX-31.2 10131
4 EX-32.1 a17-13386_1ex32d1.htm EX-32.1 12022
  Complete submission text file 0001104659-17-051181.txt   3582935

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20170630.xml EX-101.INS 543284
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lptx-20170630.xsd EX-101.SCH 39304
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lptx-20170630_cal.xml EX-101.CAL 29519
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lptx-20170630_def.xml EX-101.DEF 163054
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lptx-20170630_lab.xml EX-101.LAB 371677
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lptx-20170630_pre.xml EX-101.PRE 276741
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 171022935
SIC: 2834 Pharmaceutical Preparations